MAPT and Alzheimer disease: Current potential therapeutic strategies for AD are targeting multiple pathological mechanisms, including the normalization of tau protein phosphorylation and Aβ aggregation, enhanced clearance of Aβ plaques, modulation of neuroinflammatory pathways, and attenuation of oxidative stress through free radical scavenging.